---
title: 'Trypanosoma brucei: Metabolomics for analysis of cellular metabolism and drug
  discovery'
date: '2022-03-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/35305174/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Zkrxt7ktlCbHBXEV3v65xxSnkSWNsJ1A6Fq3gBniKhGfIUslK&fc=20210907212339&ff=20220325205949&v=2.17.6
source: metablomics[MeSH Terms]
description: 'BACKGROUND: Trypanosoma brucei is the causative agent of Human African
  Trypanosomiasis (also known as sleeping sickness), a disease causing serious neurological
  disorders and fatal if left untreated. Due to its lethal pathogenicity, a variety
  of treatments have been developed over the years, but which have some important
  limitations such as acute toxicity and parasite resistance. Metabolomics is an innovative
  tool used to better understand the parasite''s cellular metabolism, and identify
  ...'
---
BACKGROUND: Trypanosoma brucei is the causative agent of Human African Trypanosomiasis (also known as sleeping sickness), a disease causing serious neurological disorders and fatal if left untreated. Due to its lethal pathogenicity, a variety of treatments have been developed over the years, but which have some important limitations such as acute toxicity and parasite resistance. Metabolomics is an innovative tool used to better understand the parasite's cellular metabolism, and identify ...